Abbvie Inc [ABBV] stock prices are up 2.30% to $181.14 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ABBV shares have gain 8.75% over the last week, with a monthly amount drifted -4.50%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Abbvie Inc [NYSE: ABBV] stock has seen the most recent analyst activity on November 22, 2024, when Leerink Partners upgraded its rating to a Outperform but kept the price target unchanged to $206 for it. Previously, Wolfe Research started tracking the stock with Outperform rating on November 15, 2024, and set its price target to $205. On November 04, 2024, upgrade upgraded it’s rating to Buy. Bernstein started tracking the stock assigning a Mkt Perform rating and suggested a price target of $203 on October 17, 2024. HSBC Securities upgraded its rating to a Buy but $185 remained the price target by the analyst firm on June 05, 2024. Cantor Fitzgerald started tracking with a Overweight rating for this stock on May 17, 2024, and assigned it a price target of $200. In a note dated January 29, 2024, William Blair upgraded an Outperform rating on this stock.
The stock price of Abbvie Inc [ABBV] has been fluctuating between $137.65 and $207.32 over the past year. Currently, Wall Street analysts expect the stock to reach $173.3 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $181.14 at the most recent close of the market. An investor can expect a potential drop of -4.33% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
The Abbvie Inc [NYSE:ABBV] reported sales of 55.53B for trailing twelve months, representing a surge of 3.83%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.66 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 11.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 177.99 points at the first support level, and at 174.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 182.97, and for the 2nd resistance point, it is at 184.80.
Ratios To Look Out For
It’s worth pointing out that Abbvie Inc [NYSE:ABBV]’s Current Ratio is 0.65. In addition, the Quick Ratio stands at 0.54 and the Cash Ratio stands at 0.17. Considering the valuation of this stock, the price to sales ratio is 5.76, the price to book ratio is 53.07 and price to earnings (TTM) ratio is 63.17.
Transactions by insiders
Recent insider trading involved Hudson Thomas J, Officer, that happened on Aug 08 ’24 when 49170.0 shares were purchased. EXECUTIVE CHAIRMAN OF BOARD, GONZALEZ RICHARD A completed a deal on Aug 05 ’24 to sell 66500.0 shares. Meanwhile, Officer Hudson Thomas J bought 0.1 million shares on Aug 07 ’24.
